NIH-funded research R21 grant

Helping women in South Africa self-test for HIV and syphilis and connect to PrEP or treatment

Official title: Formative work to develop an intervention to support dual HIV/syphilis self-testing and linkage to PrEP and/or HIV/syphilis treatment for women in South Africa: The THANDO Study

Funded at University of Colorado Denver · NIH-11388812 · Data updated 2026-11-12

This project will design ways to help women in South Africa use combined HIV and syphilis self-tests and get linked to treatment or PrEP.

More PrEP research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Colorado Denver
NIH-funded
Lab location1 site (Aurora, UNITED STATES)
Project startJuly 15, 2024
Project endMay 31, 2027
Funding year2025
Award (this year)$68,258
NIH project number3R21MH135779-02S1
Project IDNIH-11388812 on NIH RePORTER

Who could benefit from this research

Could help

Women in South Africa who are sexually active or at risk for HIV or syphilis, including those who have never tested or who are not currently linked to care, would be ideal candidates.

Less likely to help

People who are not women, live outside South Africa, or are already fully engaged in HIV/syphilis care may not directly benefit from participation.

What this research studies

You may be invited to share your experiences in interviews or focus groups about testing, privacy, and getting care so researchers can create helpful materials and pathways. The team will pilot dual HIV/syphilis self-test kits and try different ways to link people to PrEP or treatment after a positive or at-risk result. They will work with local clinics and community members to make sure the approach fits local needs and addresses barriers like stigma, cost, and mistrust. Feedback from women and providers will shape the final package before any larger testing rollout.

Why it matters

Potential benefit: If successful, this work could help more women test regularly for HIV and syphilis and get linked quickly to PrEP or treatment, reducing infections and improving health.

How similar studies have gone: HIV self-testing has increased testing uptake in many settings, but combining HIV and syphilis self-testing with effective linkage to PrEP or treatment for women is relatively new.

Where this research is happening

  • University of Colorado Denver
    Aurora, United States
    Active

Researchers

  • Principal investigator: Rael, Christine Tagliaferri — University of Colorado Denver
  • Study coordinator: Rael, Christine Tagliaferri

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.